Cargando…
Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis”
In 2021, over 100,000 people died prematurely from opioid overdoses. Neuropsychiatric and cognitive impairments are underreported comorbidities of reward dysregulation due to genetic antecedents and epigenetic insults. Recent genome-wide association studies involving millions of subjects revealed fr...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099927/ https://www.ncbi.nlm.nih.gov/pubmed/35564876 http://dx.doi.org/10.3390/ijerph19095480 |
_version_ | 1784706727329923072 |
---|---|
author | Braverman, Eric R. Dennen, Catherine A. Gold, Mark S. Bowirrat, Abdalla Gupta, Ashim Baron, David Roy, A. Kenison Smith, David E. Cadet, Jean Lud Blum, Kenneth |
author_facet | Braverman, Eric R. Dennen, Catherine A. Gold, Mark S. Bowirrat, Abdalla Gupta, Ashim Baron, David Roy, A. Kenison Smith, David E. Cadet, Jean Lud Blum, Kenneth |
author_sort | Braverman, Eric R. |
collection | PubMed |
description | In 2021, over 100,000 people died prematurely from opioid overdoses. Neuropsychiatric and cognitive impairments are underreported comorbidities of reward dysregulation due to genetic antecedents and epigenetic insults. Recent genome-wide association studies involving millions of subjects revealed frequent comorbidity with substance use disorder (SUD) in a sizeable meta-analysis of depression. It found significant associations with the expression of NEGR1 in the hypothalamus and DRD2 in the nucleus accumbens, among others. However, despite the rise in SUD and neuropsychiatric illness, there are currently no standard objective brain assessments being performed on a routine basis. The rationale for encouraging a standard objective Brain Health Check (BHC) is to have extensive data available to treat clinical syndromes in psychiatric patients. The BHC would consist of a group of reliable, accurate, cost-effective, objective assessments involving the following domains: Memory, Attention, Neuropsychiatry, and Neurological Imaging. Utilizing primarily PUBMED, over 36 years of virtually all the computerized and written-based assessments of Memory, Attention, Psychiatric, and Neurological imaging were reviewed, and the following assessments are recommended for use in the BHC: Central Nervous System Vital Signs (Memory), Test of Variables of Attention (Attention), Millon Clinical Multiaxial Inventory III (Neuropsychiatric), and Quantitative Electroencephalogram/P300/Evoked Potential (Neurological Imaging). Finally, we suggest continuing research into incorporating a new standard BHC coupled with qEEG/P300/Evoked Potentials and genetically guided precision induction of “dopamine homeostasis” to diagnose and treat reward dysregulation to prevent the consequences of dopamine dysregulation from being epigenetically passed on to generations of our children. |
format | Online Article Text |
id | pubmed-9099927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90999272022-05-14 Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis” Braverman, Eric R. Dennen, Catherine A. Gold, Mark S. Bowirrat, Abdalla Gupta, Ashim Baron, David Roy, A. Kenison Smith, David E. Cadet, Jean Lud Blum, Kenneth Int J Environ Res Public Health Commentary In 2021, over 100,000 people died prematurely from opioid overdoses. Neuropsychiatric and cognitive impairments are underreported comorbidities of reward dysregulation due to genetic antecedents and epigenetic insults. Recent genome-wide association studies involving millions of subjects revealed frequent comorbidity with substance use disorder (SUD) in a sizeable meta-analysis of depression. It found significant associations with the expression of NEGR1 in the hypothalamus and DRD2 in the nucleus accumbens, among others. However, despite the rise in SUD and neuropsychiatric illness, there are currently no standard objective brain assessments being performed on a routine basis. The rationale for encouraging a standard objective Brain Health Check (BHC) is to have extensive data available to treat clinical syndromes in psychiatric patients. The BHC would consist of a group of reliable, accurate, cost-effective, objective assessments involving the following domains: Memory, Attention, Neuropsychiatry, and Neurological Imaging. Utilizing primarily PUBMED, over 36 years of virtually all the computerized and written-based assessments of Memory, Attention, Psychiatric, and Neurological imaging were reviewed, and the following assessments are recommended for use in the BHC: Central Nervous System Vital Signs (Memory), Test of Variables of Attention (Attention), Millon Clinical Multiaxial Inventory III (Neuropsychiatric), and Quantitative Electroencephalogram/P300/Evoked Potential (Neurological Imaging). Finally, we suggest continuing research into incorporating a new standard BHC coupled with qEEG/P300/Evoked Potentials and genetically guided precision induction of “dopamine homeostasis” to diagnose and treat reward dysregulation to prevent the consequences of dopamine dysregulation from being epigenetically passed on to generations of our children. MDPI 2022-04-30 /pmc/articles/PMC9099927/ /pubmed/35564876 http://dx.doi.org/10.3390/ijerph19095480 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Commentary Braverman, Eric R. Dennen, Catherine A. Gold, Mark S. Bowirrat, Abdalla Gupta, Ashim Baron, David Roy, A. Kenison Smith, David E. Cadet, Jean Lud Blum, Kenneth Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis” |
title | Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis” |
title_full | Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis” |
title_fullStr | Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis” |
title_full_unstemmed | Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis” |
title_short | Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis” |
title_sort | proposing a “brain health checkup (bhc)” as a global potential “standard of care” to overcome reward dysregulation in primary care medicine: coupling genetic risk testing and induction of “dopamine homeostasis” |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099927/ https://www.ncbi.nlm.nih.gov/pubmed/35564876 http://dx.doi.org/10.3390/ijerph19095480 |
work_keys_str_mv | AT bravermanericr proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis AT dennencatherinea proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis AT goldmarks proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis AT bowirratabdalla proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis AT guptaashim proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis AT barondavid proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis AT royakenison proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis AT smithdavide proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis AT cadetjeanlud proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis AT blumkenneth proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis |